Heron Therapeutics is a biotechnology company that develops medicines to address unmet medical needs. The company's product candidates utilize its proprietary Biochronomer drug delivery technology, which can deliver therapeutic levels of a wide range of otherwise short-acting pharmacological agents over a period of days to weeks with a single injection. Its product portfolio includes SUSTOL, CINVANTI (HTX-019) and HTX-011. Heron Therapeutics, Inc. was founded in 1983 and is headquartered in San Diego, California.
There are currently no products available for this company. Please contact us for more information or browse other companies.